These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8217675)

  • 1. Suggested optimum dose of zidovudine.
    Nurs Stand; 1993 Sep 29-Oct 5; 8(2):17. PubMed ID: 8217675
    [No Abstract]   [Full Text] [Related]  

  • 2. [Double-blind dose-response study of zidovudine in AIDS and advanced HIV infection. Nordic Medical Research Councils' HIV Therapy Group].
    Ugeskr Laeger; 1993 Jan; 155(2):104-7. PubMed ID: 8421854
    [No Abstract]   [Full Text] [Related]  

  • 3. A randomized, controlled trial of indinavir, zidovudine, and lamivudine in adults with advanced human immunodeficiency virus type 1 infection and prior antiretroviral therapy.
    Hirsch M; Steigbigel R; Staszewski S; Mellors J; Scerpella E; Hirschel B; Lange J; Squires K; Rawlins S; Meibohm A; Leavitt R
    J Infect Dis; 1999 Sep; 180(3):659-65. PubMed ID: 10438352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Zidovudine and human immunodeficiency virus infection: when and how to initiate treatment].
    Corzo JE; Leal M
    Med Clin (Barc); 1991 Jun; 97(5):178-80. PubMed ID: 1921546
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of late-state HIV infection.
    Millard PS
    J Fam Pract; 1997 Feb; 44(2):132-4. PubMed ID: 9040512
    [No Abstract]   [Full Text] [Related]  

  • 6. [Azidothymidine in the management of immune deficiency complex].
    Bálint Gábor S
    Orv Hetil; 1993 Aug; 134(35):1921-5. PubMed ID: 8361747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose of doubt.
    Day M
    Nurs Times; 1994 Jul 13-19; 90(28):20. PubMed ID: 8065956
    [No Abstract]   [Full Text] [Related]  

  • 8. Zidovudine: clinical experience in symptomatic HIV disease.
    Fischl MA
    AIDS Clin Rev; 1989; ():221-42. PubMed ID: 2488693
    [No Abstract]   [Full Text] [Related]  

  • 9. Zidovudine in asymptomatic HIV infection.
    Phillips AN; Sabin CA
    N Engl J Med; 1993 Dec; 329(25):1895; author reply 1895-6. PubMed ID: 8247049
    [No Abstract]   [Full Text] [Related]  

  • 10. Early zidovudine and survival in HIV infection.
    Gail MH; Mark SD
    N Engl J Med; 1992 Sep; 327(11):815; author reply 815-6. PubMed ID: 1472233
    [No Abstract]   [Full Text] [Related]  

  • 11. Haemophilia nurses ask to be warned.
    Nurs Stand; 1993 Apr 14-20; 7(30):7. PubMed ID: 8499294
    [No Abstract]   [Full Text] [Related]  

  • 12. Zidovudine helps postpone HIV symptoms.
    Katzin L
    Am J Nurs; 1989 Oct; 89(10):1264. PubMed ID: 2679096
    [No Abstract]   [Full Text] [Related]  

  • 13. Early zidovudine and survival in HIV infection. The Veterans Affairs AIDS Cooperative Studies Group.
    Hartigan PM; Hamilton JD; Simberkoff MS
    N Engl J Med; 1992 Sep; 327(11):814-5; author reply 815-6. PubMed ID: 1501668
    [No Abstract]   [Full Text] [Related]  

  • 14. A new HIV/AIDS drug.
    J Ark Med Soc; 1996 Jan; 92(8):407. PubMed ID: 8582889
    [No Abstract]   [Full Text] [Related]  

  • 15. WHO takes major steps to make HIV treatment accessible.
    J Adv Nurs; 2002 Sep; 39(6):517-8. PubMed ID: 12365403
    [No Abstract]   [Full Text] [Related]  

  • 16. One step back.
    Mason P
    Nurs Times; 1993 Apr 21-27; 89(16):19. PubMed ID: 8483753
    [No Abstract]   [Full Text] [Related]  

  • 17. [Current developments in the anti-retroviral treatment of HIV-infected patients].
    Jost J
    Schweiz Rundsch Med Prax; 1990 Jun; 79(23):745-6. PubMed ID: 2367768
    [No Abstract]   [Full Text] [Related]  

  • 18. Education needed after AZT failure.
    Nurs Stand; 1993 Apr 7-13; 7(29):6. PubMed ID: 8499278
    [No Abstract]   [Full Text] [Related]  

  • 19. FDA Committee recommends clearance for HIVID combination therapy.
    AIDS Patient Care STDS; 1996 Jun; 10(3):186. PubMed ID: 11361630
    [No Abstract]   [Full Text] [Related]  

  • 20. Soluble tumor necrosis factor receptors as surrogate markers for the assessment of zidovudine treatment in asymptomatic HIV-1 infection.
    Godfried MH; van der Poll T; Mulder JW; Weverling GJ; Endert E; Lange JM; Sauerwein HP
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Dec; 10(5):531-9. PubMed ID: 8548332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.